Radiographic Response to Yttrium-90 Radioembolization in Anterior Versus Posterior Liver Segments

被引:12
作者
Ibrahim, Saad M. [1 ]
Lewandowski, Robert J. [1 ]
Ryu, Robert K. [1 ]
Sato, Kent T. [1 ]
Gates, Vanessa L. [1 ,2 ]
Mulcahy, Mary F. [3 ]
Kulik, Laura [4 ]
Larson, Andrew C. [5 ]
Omary, Reed A. [1 ]
Salem, Riad [1 ]
机构
[1] Northwestern Univ, Dept Radiol, Sect Intervent Radiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Nucl Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Med, Div Hematol & Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[4] Northwestern Univ, Dept Med, Div Hepatol, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA
关键词
Liver metastases; Tumor response; Radioembolization; Yttrium-90; Therasphere; SIR-spheres;
D O I
10.1007/s00270-008-9348-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of our study was to determine if preferential radiographic tumor response occurs in tumors located in posterior versus anterior liver segments following radioembolization with yttrium-90 glass microspheres. One hundred thirty-seven patients with chemorefractory liver metastases of various primaries were treated with yttrium-90 glass microspheres. Of these, a subset analysis was performed on 89 patients who underwent 101 whole-right-lobe infusions to liver segments V, VI, VII, and VIII. Pre- and posttreatment imaging included either triphasic contrast material-enhanced CT or gadolinium-enhanced MRI. Responses to treatment were compared in anterior versus posterior right lobe lesions using both RECIST and WHO criteria. Statistical comparative studies were conducted in 42 patients with both anterior and posterior segment lesions using the paired-sample t-test. Pearson correlation was used to determine the relationship between pretreatment tumor size and posttreatment tumor response. Median administered activity, delivered radiation dose, and treatment volume were 2.3 GBq, 118.2 Gy, and 1,072 cm3, respectively. Differences between the pretreatment tumor size of anterior and posterior liver segments were not statistically significant (p = 0.7981). Differences in tumor response between anterior and posterior liver segments were not statistically significant using WHO criteria (p = 0.8557). A statistically significant correlation did not exist between pretreatment tumor size and posttreatment tumor response (r = 0.0554, p = 0.4434). On imaging follow-up using WHO criteria, for anterior and posterior regions of the liver, (1) response rates were 50% (PR = 50%) and 45% (CR = 9%, PR = 36%), and (2) mean changes in tumor size were -41% and -40%. In conclusion, this study did not find evidence of preferential radiographic tumor response in posterior versus anterior liver segments treated with yttrium-90 glass microspheres.
引用
收藏
页码:1124 / 1132
页数:9
相关论文
共 47 条
[1]   Evaluation of glass microspheres for intra-arterial radiotherapy in animal kidneys [J].
Araki, N ;
Nagata, Y ;
Fujiwara, K ;
Aoki, T ;
Mitsumori, M ;
Kimura, H ;
Itasaka, S ;
Saitou, H ;
Hiraoka, M ;
Kawashita, M ;
Kokubo, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (02) :459-463
[2]  
BARTOLOZZI C, 2003, LIVER MALIGNANCIES
[3]   REGIONAL TRAPPING OF MICROSPHERES IN THE LUNG COMPARES WELL WITH REGIONAL BLOOD-FLOW [J].
BECK, KC .
JOURNAL OF APPLIED PHYSIOLOGY, 1987, 63 (02) :883-889
[4]  
BREEDIS C, 1954, AM J PATHOL, V30, P969
[5]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[6]   Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy [J].
Campbell, AM ;
Bailey, IH ;
Burton, MA .
PHYSICS IN MEDICINE AND BIOLOGY, 2000, 45 (04) :1023-1033
[7]   Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy [J].
Campbell, AM ;
Bailey, IH ;
Burton, MA .
PHYSICS IN MEDICINE AND BIOLOGY, 2001, 46 (02) :487-498
[8]  
Carr Brian I, 2004, Liver Transpl, V10, pS107, DOI 10.1002/lt.20036
[9]  
Dancey JE, 2000, J NUCL MED, V41, P1673
[10]   Yttrium-90 microspheres for the treatment of hepatocellular carcinoma [J].
Geschwind, JFH ;
Salem, R ;
Carr, BI ;
Soulen, MC ;
Thurston, KG ;
Goin, KA ;
Van Buskirk, M ;
Roberts, CA ;
Goin, JE .
GASTROENTEROLOGY, 2004, 127 (05) :S194-S205